Baptist Health South Signs Medline as its Exclusive Distributor for Medical Products

Medline today announced a multi-year prime vendor partnership with Florida-based Baptist Health South Florida.

The two organizations will partner to identify new strategies for enhancing data-driven operational and clinical efficiencies. As the system’s primary supplier, Medline will exclusively provide an extensive portfolio of essential medical supplies and solutions across the health system’s 12 hospitals and more than 200 outpatient centers and physician practices.

“We strive to be a world-class, value-based supply chain that drives financial and operational excellence for our system, which is a goal further supported by our partnership with Medline,” said George S. Godfrey, corporate vice president and chief supply chain officer at Baptist Health South Florida. “From the beginning, Medline has been open and receptive to exploring together new ways to better leverage technology to streamline and advance operations for our industry.”

Known for its industry-leading supply chain operations, Baptist Health South Florida will partner with Medline to optimize supply chain processes by leveraging data and technology to eliminate non-value-added activities and enhance financial and operational performance. As part of the strategic relationship, Baptist Health South Florida will have the ability to integrate key metrics such as item utilization, contract compliance, price accuracy, and spend by product categories through a collaborative analytics-integration process. The two organizations are committed to developing new ways to enhance supply chain operations and patient care through data.

“When Medline becomes an extension of a team, as we have with Baptist Health South Florida, our shared commitment to data accuracy and accountability enables us both to reach new levels of actionable insights,” says Jen Cerami, executive account director at Medline. “The Baptist Health South Florida team challenges me to think differently. I am excited to evolve together as we tackle supply chain challenges and create customized, cutting-edge solutions to help healthcare run better.”

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.